Annual Cash & Cash Equivalents
$141.64 M
+$64.43 M+83.46%
31 December 2021
Summary:
Concert Pharmaceuticals annual cash & cash equivalents is currently $141.64 million, with the most recent change of +$64.43 million (+83.46%) on 31 December 2021. During the last 3 years, it has risen by +$64.43 million (+83.46%).CNCE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$95.19 M
-$44.06 M-31.64%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly cash and cash equivalents is currently $95.19 million, with the most recent change of -$44.06 million (-31.64%) on 30 September 2022.CNCE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +83.5% | -8.2% |
| 5 y5 years | +697.0% | +185.1% |
CNCE Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -32.8% |
Concert Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $95.19 M(-31.6%) |
| June 2022 | - | $139.25 M(+134.6%) |
| Mar 2022 | - | $59.36 M(-58.1%) |
| Dec 2021 | $141.64 M(+83.5%) | $141.64 M(+36.6%) |
| Sept 2021 | - | $103.66 M(-15.3%) |
| June 2021 | - | $122.40 M(+36.3%) |
| Mar 2021 | - | $89.77 M(+16.3%) |
| Dec 2020 | $77.20 M(+45.5%) | $77.20 M(+129.3%) |
| Sept 2020 | - | $33.67 M(+24.3%) |
| June 2020 | - | $27.09 M(-41.2%) |
| Mar 2020 | - | $46.08 M(-13.1%) |
| Dec 2019 | $53.04 M(+198.5%) | $53.04 M(+58.9%) |
| Sept 2019 | - | $33.38 M(-23.6%) |
| June 2019 | - | $43.71 M(-27.5%) |
| Mar 2019 | - | $60.26 M(+239.1%) |
| Dec 2018 | $17.77 M(-35.8%) | $17.77 M(-55.1%) |
| Sept 2018 | - | $39.60 M(-32.1%) |
| June 2018 | - | $58.36 M(+63.5%) |
| Mar 2018 | - | $35.70 M(+29.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $27.66 M(-31.8%) | $27.66 M(-13.9%) |
| Sept 2017 | - | $32.12 M(+16.4%) |
| June 2017 | - | $27.59 M(-1.8%) |
| Mar 2017 | - | $28.11 M(-30.7%) |
| Dec 2016 | $40.55 M(-56.2%) | $40.55 M(+36.1%) |
| Sept 2016 | - | $29.80 M(-44.5%) |
| June 2016 | - | $53.65 M(+41.9%) |
| Mar 2016 | - | $37.82 M(-59.1%) |
| Dec 2015 | $92.51 M(+590.6%) | $92.51 M(+346.7%) |
| Sept 2015 | - | $20.71 M(-8.2%) |
| June 2015 | - | $22.57 M(-64.6%) |
| Mar 2015 | - | $63.82 M(+376.4%) |
| Dec 2014 | $13.40 M(+39.0%) | $13.40 M(-42.8%) |
| Sept 2014 | - | $23.44 M(+30.8%) |
| June 2014 | - | $17.92 M(-54.8%) |
| Mar 2014 | - | $39.65 M(+311.4%) |
| Dec 2013 | $9.64 M(+28.7%) | $9.64 M(-48.2%) |
| Sept 2013 | - | $18.61 M(+148.5%) |
| Dec 2012 | $7.49 M(-67.4%) | $7.49 M |
| Dec 2011 | $22.95 M | - |
FAQ
- What is Concert Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CNCE is $141.64 M
What is the all time high annual cash & cash equivalents for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual cash & cash equivalents is $141.64 M
What is Concert Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CNCE is $95.19 M
What is the all time high quarterly cash and cash equivalents for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly cash and cash equivalents is $141.64 M